Long-term follow-up of topical 5-aminolaevulinic acid photodynamic therapy diode laser single session for non-melanoma skin cancer.

[1]  P. Steijlen,et al.  Fractionated 5‐aminolaevulinic acid–photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial , 2008, The British journal of dermatology.

[2]  J. Ferreira,et al.  A terapia fotodinâmica com ácido 5-aminolevulínico como modalidade de tratamento para neoplasias cutâneas não-melanoma , 2008 .

[3]  C. Sibata,et al.  A clinical review of PDT for cutaneous malignancies. , 2006, Photodiagnosis and photodynamic therapy.

[4]  W. Star,et al.  Topical 5-aminolaevulinic acid mediated photodynamic therapy of superficial basal cell carcinoma using two light fractions with a two-hour interval: Long-term follow-up , 2006 .

[5]  C. Morton.  How to optimise topical photodynamic therapy in dermatology. , 2006, Photodiagnosis and photodynamic therapy.

[6]  V. Bagnato,et al.  Topical photodynamic therapy for Bowen's disease of the digit in epidermolysis bullosa , 2005, The British journal of dermatology.

[7]  M. Landthaler,et al.  Photodynamic therapy in dermatology – an update , 2005, Photodermatology, photoimmunology & photomedicine.

[8]  S. Ibbotson,et al.  Photodynamic therapy in dermatology: Dundee clinical and research experience. , 2004, Photodiagnosis and photodynamic therapy.

[9]  Stanley B. Brown,et al.  The present and future role of photodynamic therapy in cancer treatment. , 2004, The Lancet. Oncology.

[10]  David J Goldberg,et al.  A Review of Laser and Photodynamic Therapy for the Treatment of Nonmelanoma Skin Cancer , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[11]  H. Wulf,et al.  Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment , 2003, The British journal of dermatology.

[12]  S. Ibbotson,et al.  Topical 5‐aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources , 2003, Photodermatology, photoimmunology & photomedicine.

[13]  M. Ericson,et al.  Pain caused by photodynamic therapy of skin cancer , 2002, Clinical and experimental dermatology.

[14]  H Moseley,et al.  Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group , 2002, The British journal of dermatology.

[15]  K. Giercksky,et al.  A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. , 2001, The British journal of dermatology.

[16]  A. Anstey,et al.  Bowen’s disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large‐field incoherent light source , 2001, The British journal of dermatology.

[17]  C. Whitehurst,et al.  Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. , 2001, Archives of dermatology.

[18]  C. Whitehurst,et al.  Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid‐based photodynamic therapy , 2000, The British journal of dermatology.

[19]  M. Thissen,et al.  SHORT COMMUNICATIONPhotodynamic therapy with delta‐aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique , 2000, The British journal of dermatology.

[20]  A. Berner,et al.  Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study. , 1999, Acta dermato-venereologica.

[21]  M Landthaler,et al.  Simulations on the selectivity of 5-aminolaevulinic acid-induced fluorescence in vivo. , 1998, Journal of photochemistry and photobiology. B, Biology.

[22]  J H McColl,et al.  Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response. , 1998, Archives of dermatology.

[23]  J Moan,et al.  5‐Aminolevulinic acid‐based photodynamic therapy , 1997, Cancer.

[24]  C. Whitehurst,et al.  Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease , 1996, The British journal of dermatology.

[25]  P. Calzavara-Pinton,et al.  Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. , 1995, Journal of photochemistry and photobiology. B, Biology.

[26]  J. Hill,et al.  A history of photodynamic therapy. , 1991, The Australian and New Zealand journal of surgery.

[27]  J. Kennedy,et al.  Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.

[28]  A. Oseroff,et al.  Aminolevulinic acid photodynamic therapy for skin cancers. , 2007, Dermatologic clinics.

[29]  Ann-Marie Wennberg,et al.  Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. , 2007, Journal of the American Academy of Dermatology.

[30]  Thomas J. Flotte,et al.  Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment , 2004, Archives of Dermatological Research.